Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Depreciation and Depletion: 2017-2025

Historic Depreciation and Depletion for Rockwell Medical (RMTI) over the last 9 years, with Sep 2025 value amounting to $400,000.

  • Rockwell Medical's Depreciation and Depletion changed negligibly% to $400,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $1.6 million for FY2024, which is 33.33% up from last year.
  • As of Q3 2025, Rockwell Medical's Depreciation and Depletion stood at $400,000, which was down 0.00% from $400,000 recorded in Q2 2025.
  • Rockwell Medical's 5-year Depreciation and Depletion high stood at $400,000 for Q3 2023, and its period low was $100,000 during Q3 2021.
  • In the last 3 years, Rockwell Medical's Depreciation and Depletion had a median value of $400,000 in 2025 and averaged $363,636.
  • As far as peak fluctuations go, Rockwell Medical's Depreciation and Depletion crashed by 50.00% in 2021, and later spiked by 300.00% in 2023.
  • Rockwell Medical's Depreciation and Depletion (Quarterly) stood at $168,000 in 2021, then grew by 19.05% to $200,000 in 2022, then soared by 100.00% to $400,000 in 2023, then remained steady at $400,000 in 2024, then remained steady at $400,000 in 2025.
  • Its Depreciation and Depletion was $400,000 in Q3 2025, compared to $400,000 in Q2 2025 and $400,000 in Q1 2025.